NCAB Group (NCAB) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
23 Apr, 2026Executive summary
Order intake grew 27% year-over-year to SEK 1,289 million, with up to 49% growth in USD, reflecting strong market recovery and major project wins, especially in North America.
Net sales increased 12% to SEK 1,074 million, with 24% organic growth in USD and stable gross margin at 34.9%.
EBITA/EBITDA rose to SEK 128.2 million (up from SEK 100 million), with margin improving to 11.9%.
Net profit reached SEK 75 million, up from SEK 52 million, and EPS improved to SEK 0.40 from SEK 0.28.
Market recovery is driven by industrial, medtech, defense, and power, while automotive remains muted.
Financial highlights
Book-to-bill ratio at 1.20, with order intake up 27% in SEK and 43% in USD.
Gross profit grew to SEK 374.5 million, gross margin stable at 34.9%.
Operating cash flow increased to SEK 65.8 million, up from SEK 53.3 million.
Return on equity improved to 15.6% (up from 15.1%).
Dividend of SEK 1.10 per share proposed by the Board.
Outlook and guidance
Price increases in order intake expected to impact net sales from Q2 and more significantly in H2 2026.
Defense invoicing expected to continue through 2026 and into 2027, supported by backlog.
Market capacity constraints and longer lead times anticipated due to AI data center investments.
Strategy remains focused on organic growth, technology investment, and M&A for geographic expansion and market consolidation.
Positive trends expected to persist in defense, medtech, and power sectors.
Latest events from NCAB Group
- Strong Q4 growth, margin gains, and acquisition offset full-year FX-driven margin decline.NCAB
Q4 202513 Apr 2026 - Sales and profit fell, but margin, M&A, and North America orders support future growth.NCAB
Q2 20243 Feb 2026 - Sales and profit fell on weak Europe, but margins held and acquisitions support future growth.NCAB
Q3 202416 Jan 2026 - Order intake up 5%, EBITA margin down, dividend suspended amid market uncertainty.NCAB
Q1 202524 Dec 2025 - Q4 sales and profit fell on weak Europe, but order intake and acquisitions support future growth.NCAB
Q4 202423 Dec 2025 - Order intake rose 5% and USD sales grew, but margins fell due to FX and product mix.NCAB
Q2 202516 Nov 2025 - Strong order intake and sales growth, but EBITA margin declined on FX and mix impacts.NCAB
Q3 202524 Oct 2025